According to Renub Research In Situ Hybridization (ISH) Market is projected to grow from US$ 1.73 billion in 2024 to US$ 3.22 billion by 2033, expanding at a CAGR of 7.14% during 2025–2033. Growth is driven by the increasing use of ISH techniques in cancer diagnostics, infectious disease research, and genetic testing. Technological advancements—especially in imaging, probe development, and automated platforms—continue to enhance precision, sensitivity, and throughput in molecular and cellular analysis.
Global In Situ Hybridization Market OutlookIn Situ Hybridization is a molecular technique designed to locate and detect specific DNA or RNA sequences directly within tissue sections or cell samples. By using labeled complementary probes that bind to target genetic material, ISH allows researchers and clinicians to visualize gene expression, chromosomal …